Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 313
--> Appendix L Passing the Test: New York's Newborn HIV Testing Policy, 1987–1997 David Abramson Introduction This appendix traces the evolution of policy in New York State regarding the screening of newborns for HIV antibodies, from the introduction of the blinded newborn seroprevalence survey in November 1987 through the implementation of the mandatory newborn testing and notification begun in February 1997. It is intended to provide the reader with the context in which key policies were debated or enacted and a sense of who the key players were. A caveat for the reader: since this material spans over a decade's worth of activity and discourse around a highly charged emotional issue, as a chronological accounting it can only touch upon key events and personalities. Moreover, an effort has been made to present the issues and decisions objectively by outlining the arguments advanced for certain decisions or policies, rather than arguing the merits of one point of view over another. Data for this appendix were collected through confidential key informant interviews, literature reviews, and archival material review (such as program documentation and newspaper reports). Because many of the informants are currently involved in policy making and public health activities and might otherwise feel constrained from being completely candid if their comments would be publicly attributed, individuals' insights and comments have been intertwined within the narrative without identifiable attribution. This particular case of newborn screening policy in New York offers insights into the state's broader politics and policy making surrounding HIV/AIDS. Several of the key lessons include the following:
OCR for page 314
--> Policies and advocacy efforts from the 1960s through the 1990s produced a confluence of the patients' right movement, community engagement models, and categorical funding streams that resulted in a public health environment far more sensitive to individual privacy rights, patient autonomy, special interests and particularized communities than the more traditional mandate of public health operating solely for a majoritarian ''public good." Advocates for people affected by HIV/AIDS have consistently challenged the traditional public health roles of surveillance, resource distribution, and case finding—and particularly the consequences of these traditional policies and programs for disenfranchised populations—and in so doing have compelled "exceptionalist" policies regarding HIV/AIDS that differ in many important aspects from other communicable or sexually transmitted diseases (STDs). New York's newborn screening debate embodied the struggle between the traditional and the exceptionalist approaches. As the issue of newborn surveillance evolved from an insular public health issue to one of political moment, who framed the issue and how the issue was framed became the two most important predictors of public opinion. The locus of decision making shifted over the course of a decade, as did the arena in which debate was engaged. Once public health policy was being debated in a political arena (and particularly once it reached a certain crescendo), the ultimate decisions and considerations were more often related to their political consequences than to their health consequences. When the testing policy changed in 1996 and 1997 (first with "consented" testing and then with mandatory testing), this occurred primarily because of shifting political winds and not because of scientific sea changes. As originally conceived, the state's newborn screening program addressed "public health uncertainty" about the epidemiology of HIV, but could not resolve the "medical uncertainty" of a clinician unaware of a patient's status, and therefore reinforced the divide between the population orientation of the state and the patient orientation of the clinician. Although New York's initial newborn testing policy revolved around surveillance and its epidemiological utility for charting the epidemic and for program planning, the legislative battle focused on newborn testing for the purposes of case finding. When the political debate was first engaged in 1993, there was scant evidence that mandatory testing would result in any decrease in perinatal transmission. Although there was a consensus regarding secondary prevention of Pneumocystis carinii pneumonia (PCP) among infants using penta-midine prophylactically, and the Centers for Disease Control and Prevention (CDC) had issued guidelines regarding HIV-positive mothers abstaining from breast-feeding (which might be delayed up to six weeks awaiting test results and follow-up), the medical and public health communities were divided on the absolute benefit of newborn testing as a means of reducing perinatal transmission. Even as the scientific landscape changed (particularly concerning the clear evidence
OCR for page 315
--> for intervening in the prenatal period) the terms of the newborn testing debate remained fixed. Given the advent of rapid testing and the potential value of zidovudine (ZDV) therapy antenatally, medical science is only now beginning to demonstrate any evidence for proactively identifying HIV-antibody-carrying infants at birth. The cornerstones of the political discourse on the testing policy, though, were predicated on emotional and political issues, not scientific ones. Furthermore, as a case finding tool, newborn testing was principally effective only in identifying the mother. When the issue was first raised legislatively in 1993, there was no system of follow-up care or any reliable way to assure that all HIV-positive babies were accurately identified when they seroconverted. Given the players, the program, and the shifting political environment, it is likely that mandatory testing was inevitable in New York State. The mandatory newborn testing policy has also facilitated the successful passage of other HIV legislation in New York, such as mandatory partner notification and named HIV reporting. The chronology of newborn testing policy unfolded in a shifting context of decision making and debate: from insular public health (the pragmatic era), to the population/clinical split (the era of mounting clinical frustration), to the political arena (marked by polarization, issue framing, and political "processes" of negotiation and pressure), to clinical optimism (retroviral therapy and protease inhibitors), and a return to public health pragmatism (the implementation of a political decision). There were two points of strong federal state interaction regarding newborn screening, and the nature of each reveals a great deal about the shifting eras. In 1987, the CDC strongly supported New York's surveillance efforts as a complement to its "Family of Surveys" and provided half the ongoing funding for New York's newborn screening program. This was clearly the era of public health pragmatism, particularly in the face of uncertainty about the epidemic's future path. In 1995–1996, there was increasing political momentum at the federal level (evidenced by amendments to the Ryan White Reauthorization Act proposed by Congressmen Tom Coburn and Gary Ackerman) for mandatory newborn testing. With the sweep of Republicans into U.S. Congress, and similar Republican inroads in the New York State legislature (and the change at the executive level from a Democratic to a Republican governor), the Democratic-controlled Assembly faced increasing political pressure to conform to the governor's wishes for a mandatory newborn testing program. In 1996, after quiet negotiations between several key legislative players, the New York State Assembly speaker reversed his three-year opposition to mandatory testing and helped pass the "Baby AIDS" bill. The framing and marketing of the issue of newborn screening and testing played a significant part in the decisions and actions taken. The early blinded screening program publicized its findings of high seroprevalence rates among
OCR for page 316
--> women in inner-city communities, and the news was presented as that of epidemiologic discovery. The emerging pattern of HIV transmission—with its growing impact on communities of heterosexual women and their offspring, in some neighborhoods as high as 4%—served as the impetus for a number of prevention and education efforts. In contrast, once the issue entered the political arena, the debate was waged in the realm of public opinion. Those who favored mandatory newborn testing presented the issue as one of villains and victims. The villain in this case was "Big Brother" government, armed with specific knowledge about a baby that could save his/her life, thwarting the victims—dedicated doctors and caring mothers—from saving HIV-infected babies. The counterarguments were far subtler, often relying upon biostatistical arguments, legal or ethical frameworks, or advocacy on behalf of minority women. Although those opposed to mandatory testing advocated a model of voluntary HIV testing, which presumably worked to foster trust between a health care provider and a mother and capitalized on maternal instincts to protect a baby's welfare, the images could not compete with those of HIV-infected babies being denied treatment by an uncaring government. Finally, what state public health officials had recognized early on—that using the sentinel event of birth as a primary epidemiological marker because it was universal, occurred in an institutional setting over which the state had considerable regulatory power, and was built upon a successful newborn genetic screening program—carried equal appeal for policy makers. Whether the state was interested in HIV surveillance or case finding, the birth of a baby appeared to provide a perfect opportunity. The Public Health Environment, 1980–1986 New York's city and state health departments confronted a number of sensitive issues in the first few years of the AIDS epidemic: the regulation of sexual behavior in commercial bathhouses, clean needle exchanges for injection drug users, and the development of voluntary HIV testing programs, among others. Each issue posed its own policy challenge. In considering bathhouse closures, public health officials weighed the benefit of using their police powers against the consequence of threatening a particular group's civil liberties. With proposed needle exchange programs, they tried to balance the moralism of antidrug policies and politics with the pragmatism of stemming an avenue of transmission. As HIV tests became available in 1985, officials had the task of inspiring trust among groups that were wary of a government's ability to preserve an individual's privacy and confidentiality. From the debates that arose among public health officials, interest groups and affected individuals, health care providers, and political leaders, a general strategy of voluntary risk reduction and HIV prevention programs emerged. Rather than use their prerogative to close gay bathhouses, bars, and other public venues, public health officials first sought voluntary compliance
OCR for page 317
--> from the gay community. Only after the voluntary effort had failed did the state compel the closure of commercial bathhouses. The health commissioners had less success with needle exchange programs. Although sequential New York City Health Commissioners David Sencer and Stephen Joseph both endorsed needle exchange programs, and New York State Health Commissioner David Axelrod was also willing—albeit reluctantly—to experiment with such approaches, the proposed programs generated too much political opposition. It was not until 1989 that a limited needle exchange demonstration was approved for New York City. The lessons reinforced by these two issues were clear: individual rights matter and politics matter. To craft strategic programs, public health officials had to appease civil libertarians and advocacy groups at one end of the political spectrum and political conservatives at the other end. The HIV antibody test developed in 1985 as a means of safeguarding the blood supply raised the greatest specter of government intrusion into an individual's private domain. Although public health officials did not universally endorse a voluntary HIV testing program initially (it was, in fact, opposed initially by the city health commissioner), by the end of 1985 most health officials acknowledged the test's utility for preventing transmission of the virus. The HIV test, however, was regarded by its opponents as the linchpin for a number of potentially intrusive measures—registries of HIV -infected individuals (which could both stigmatize and lead to discrimination if the names were ever revealed), mandatory partner notification programs, impingement of women's reproductive choices, and potential deportation of infected immigrants. In response to these concerns, public health officials and policy makers reinforced the exceptionalist nature of AIDS policy—rather than using the traditional reporting requirements and contact tracing associated with sexually transmitted and other communicable diseases, New York health officials carved out explicit informed consent requirements and voluntary HIV testing and notification policies. Behind such policies was an implicit quid pro quo. In return for relying upon various risk groups' voluntary compliance with these prevention strategies, public health officials would withhold a compulsory approach. Given the absence of any reliable treatment in the mid- 1980s, public health officials' reliance upon voluntary prevention efforts seemed the most prudent course of action. New York's innovative administration of its AIDS programs further reflected its awareness that this disease required a different approach than others. The AIDS Institute was established as an independent center within the state health department in 1982, at first reporting to the director of the Center for Community Health (an umbrella unit for all community-based public health activities) and later reporting directly to the commissioner of health. The broad mandate of the AIDS Institute included strategic planning, the oversight of community and clinical programs, the synthesis of epidemiological and evaluation data for planning purposes, and policy development. The Bureau of HIV/AIDS Surveillance operated separately from the AIDS Institute and worked as a component
OCR for page 318
--> of the state's epidemiology unit. The surveillance group was responsible for analyzing data provided by the state's Wadsworth Laboratory, which represented the third leg of the administrative tripod. Finally, the state legislature created the AIDS Advisory Council (staffed by the AIDS Institute) as a forum to provide the health commissioner with input from both health care providers and communities affected by AIDS. The AIDS Advisory Council served as a buffer between vocal community advocacy groups, program planners within the health department, and the state legislature. Among the council's roles were developing proposed statewide AIDS budgets, identifying special needs populations, and lobbying politicians on designated "Legislators Days." According to one knowledgeable observer, "The AIDS budget is unique. It is laid out in lines that are more specific than the overall department's budget, because of visibility and political action. Each group of constituencies is represented in a separate line, such as a budget line for 'High risk women and children.'" Prior to the current administration, which began in 1995, the AIDS Institute also had its own policy office, distinct from the health department's, which oversaw an interagency policy committee that coordinated the AIDS policy work of a number of state agencies and units. AIDS policy in New York was clearly exceptional and political, and the locus of decision making was in the hands of Dr. David Axelrod, the state's health commissioner. Public Health Pragmatism, 1987–1990 At the Third International AIDS Conference in Washington, D.C. in the summer of 1987, the State of Massachusetts reported on its anonymous newborn screening program for HIV antibodies, which had been operational for a year. The first state in the nation to conduct such surveillance, Massachusetts had capitalized on its newborn screening program for genetic and metabolic disorders in order to test for the presence or absence of maternal HIV antibodies in a baby's blood. Two high-ranking New York public health officials, Lloyd Novick, the director of the Center for Community Health (which oversaw both the epidemiology unit and the AIDS Institute at the time), and Donald Berns, the assistant director of the state-run Wadsworth Center for Laboratories and Research, were very impressed by Massachusetts's presentation. Berns assured Novick that they had the laboratory capacity to conduct such a surveillance effort in New York. They returned to New York intent on developing an even more sophisticated screening program. The two met with Health Commissioner David Axelrod and Herbert Dickerman, the head of the Wadsworth Labs, and began planning the newborn surveillance program. From the onset, the four determined to improve on the Massachusetts surveillance program by also collecting demographic data, including the zip code of the mother (or the hospital if the mother's zip code was unavailable), maternal age, and the race/ethnicity of the infant. Although the planners' principal concerns at first were those of logistics and
OCR for page 319
--> capacity—securing a sufficient blood sample from a newborn heel-stick; designing the data form for accurate coding; removing identifiers; developing the epidemiological framework to use the data collected by the labs, conduct small- and large-area analyses, and report findings—the health department officials acknowledged in their meetings that the issue of dealing with HIV -positive results was of some concern. The universal newborn screening program had to be built on research conducted on anonymous blood samples. If mothers were approached for consent to test their newborn's blood it would raise issues of potential bias, since not all mothers would consent and the resultant sample might not be representative of the population of childbearing women. Since the surveillance therefore had to be conducted in anonymous fashion, "blinded" to those drawing the blood and those analyzing the blood, the health department had no legal authority or capacity to then identify those babies testing HIV-positive and notify the mother. In addition to the planned newborn serosurvey, New York public health officials were also designing serosurveys that provided epidemological data among population "windows" for whom blood was routinely collected—drug users, state prisoners, runaways and homeless teens referred to medical examinations, and family planning and STD clients, in addition to newborns. The decision to launch the blinded newborn seroprevalence survey and related serosurveys rested with these four public health officials, and principally with Health Commissioner Axelrod. As one of Governor Cuomo's most trusted cabinet members, Axelrod was afforded a great deal of latitude in formulating public health policy and was well respected by members of the state legislature. Axelrod's management style was such that he relied upon a close circle of high-ranking deputies for their counsel, and all major decisions funneled up to him. To assure himself that his strategies were sound both scientifically and ethically, Axelrod often convened committees of outside experts to consider the effectiveness, consequence, or significance of particular policies or programs. In mid-September 1987, Axelrod brought together clinicians and ethicists to review the gamut of proposed seroprevalence surveys—the "windows" into various populations—and particularly the newborn screening study. The Advisory Committee (composed of Elaine Abrams of Harlem Hospital, Daniel Callahan of the Hastings Center, Victor DeGruttola of Harvard School of Public Health, Richard Kaslow from the National Institute for Allergy and Infectious Diseases, the CDC's Magarite Pappaioanou, and Warren Winkelstein from the University of California at Berkeley) unanimously supported the universal newborn screening program. The blinded newborn seroprevalence study built upon the state's established Newborn Screening Program (NSP), which tested infants at hospital discharge for seven inherited disorders (phenylketonuria [PKU], congenital hyperthyroidism, and maple sugar urine disease, among others) by drawing blood through a heel-stick. The NSP had been developed in New York State in the early 1960s by a Buffalo microbiologist Dr. Robert Guthrie. He had watched in horror as his niece had gone undiagnosed with PKU until she was 16 months old; she grew up
OCR for page 320
--> retarded and schizophrenic, which he attributed to the initially undiagnosed PKU. His impetus to develop the newborn screening was that if PKU was detected early enough after birth, babies could be put on a special low-protein diet and go on to lead perfectly normal lives. On average, New York screens over 300,000 infants each year and identifies approximately 12 children with PKU. (In contrast, in a nine-month period from February 1, 1997, through October 31, 1997, of 185,540 births there were 779 infants born with maternal HIV antibodies.) The state health department began collecting newborn HIV seroprevalence data on November 30, 1987. "What I recall quite vividly," said one of the study planners, "is that after the first two weeks we were taken aback by the results. They had quite an impact on us." Several earlier newborn studies conducted in municipal hospitals in New York City had revealed seroprevalence rates of 2.4% to 2.5%. The study planners expected to find similar data in high-risk neighborhoods and were stunned to find rates of 4% seroprevalence in Harlem, the South Bronx, and the Bedford Stuyvesant section of Brooklyn. "This meant that 1 of every 25 women [delivering a baby] was infected,'' noted a public health official, "and when we reported that we expected a big outcry, and a large media push, for us to immediately unblind the survey." To their surprise, newspaper coverage focused on the epidemiological significance of the findings—on the spread of HIV infection across the state and the depth of HIV seroprevalence in particular communities. Within four weeks of starting the newborn seroprevalence study, the state health department had amended the contracts of state-regulated family planning programs and prenatal care clinics, which served over 300,000 women annually, requiring them to provide on-site HIV counseling and testing services. The state also stepped up its efforts to reach pregnant women in high-risk neighborhoods through its Community Health Worker program and through targeted education campaigns, and advised obstetricians and other physicians throughout the state of the compelling need to provide HIV counseling and testing services to women of reproductive age. In his State of the State message on January 6, 1988, Governor Mario Cuomo told the assembled legislators, "There is no greater tragedy than the birth of a child condemned to death, yet estimates indicate 1,000 infants will be born with the AIDS virus in 1988. … The initial results of the prevalence studies have only served to heighten our sense of urgency and to focus dramatically upon our most vulnerable populations. Results on the first 11,000 newborn blood specimens demonstrate an alarming statewide HIV seroprevalence rate of almost 1% among women of childbearing age." At the same time that New York was beginning its seroprevalence studies, the CDC was initiating its Family of Surveys seroprevalence sample studies in 45 states. The CDC funded states to conduct anonymous seroprevalence studies on representative samples of injection drug users, STD and tuberculosis clinic patients, hospital admissions, patients at clinics serving women or reproductive age, and newborns. New York public health officials decided to conduct universal,
OCR for page 321
--> anonymous screening rather than sampled screening, since it was piggybacking the study on the universal Newborn Screening Program and the additional cost was warranted by the greater predictive power of conducting a universal test. The CDC contributed funding that covered half of New York's seroprevalence studies, and the state made up the difference (by 1996, the state was paying three-quarters of the cost of the seroprevalence surveys, and CDC one-quarter of the $2 million program). As Novick was to write later (Novick, 1991), the newborn seroprevalence survey provided the state health department with three critical elements: currency, relevance, and focus. The "currency" allowed the state to monitor the real-time spread of the infection without having to account for the lag time between HIV infection and a reported AIDS case (and it enabled the state to conduct analyses of HIV trends over time without adjusting for the CDC's expanded definition of AIDS in 1993); the "relevance" of the universal screening test enabled the state to report actual, rather than projected, infection rates among childbearing women and to closely estimate the rate among all women ages 15–44; and the ''focus" derived from the small-area planning that could be conducted given the sociodemographic variables of maternal age, race/ethnicity, and zip code. The last was perhaps the most important to state public health officials, since it served as an early-warning system that alerted them to what communities the virus was moving into, and thereby provided an opportunity for targeted prevention and education efforts. In March 1988, Commissioner Axelrod reconvened a special advisory committee to review the preliminary results of the newborn serosurvey. The committee (composed of Elaine Abrams and Margaret Heagarty of Harlem Hospital, NIAID's Richard Kaslow, the CDC's Timothy Dondero and Margaret Oxtoby, Myron Essex and Harvey Fineberg of Harvard School of Public Health, Keith Krasinski of Bellevue Hospital, Peter Selwyn of Montefiore Hospital, and Isaac Weisfuse of the New York City Department of Health) strongly recommended continuing the serosurvey, particularly for purposes of monitoring the epidemic. Only days before the advisory committee met, an article in Newsday (a major New York daily) featured an interview with Dr. Rodney Hoff, the architect of the Massachusetts health department's blinded newborn survey. Even as he presented the rationale for the blinded serosurvey, "… so that we can monitor HIV infection trends in women," he did sound a cautionary note, saying that, "there is a trade-off here between the legal issue of consent and ethical issue of duty to inform." Since there was no accepted treatment at the time, Hoff said he considered it ethically acceptable to not identify individual patients (a position adopted by Bayer and others (1986), and by the journal Nature's editorialists in a 1987 article). "Once there is an effective treatment for infected infants," he concluded, "we will very quickly convert to a case-detection system." Between 1988 and 1990, the New York State health department pursued a number of measures predicated on voluntary adherence to primary and secondary
OCR for page 322
--> prevention practices. In the absence of a treatment or vaccine, public health strategies focused first on preventing initial infection (primary prevention) by modifying risk behaviors and, for those infected, on preventing further spread of the virus (secondary prevention). Tertiary prevention efforts, focused on limiting the progression of the disease within an infected individual, were for the most part limited to PCP prophylaxis and experimental antiretroviral therapies. As has been extensively documented, since HIV/AIDS raised so many issues of the authority of the public health officials to intervene in the private affairs of selected communities (e.g., gay bathhouse closures, mandatory partner notification) and since there had been sufficient numbers of cases of HIV/AIDS discrimination in housing, public schools, and employment to warrant a genuine concern, public health officials generally believed that the most expeditious prevention strategy had to be voluntarily elicited, rather than coerced or mandated. Furthermore, such an approach followed the principle of the "least restrictive alternative" in gauging appropriate public health action. 1 Particularly given some of the early successes in persuading the homosexual male population to voluntarily reduce risky behaviors, it seemed sensible to public health officials and legislators to pursue measures that educated and engaged the communities most at risk, rather than potentially alienating these communities and driving them away from the health care system. In keeping with this approach, the state legislature passed New York State's confidentiality statute in 1988, which imposed strict penalties for disclosure of confidential HIV information and required written informed consent prior to any HIV testing. According to one of the key legislators involved in drafting the law, "We recognized that there was an urgent public health need to have people come forward and be tested, to be counseled, and to cooperate, and since there was no lure of treatment we had to offer a guarantee of confidentiality." One key provision of the statute gave physicians treating HIV-infected individuals the "power" to warn others who might be at risk of HIV infection, but not the "duty" to warn. This was in keeping with the balance between prevention and case finding, as was the language of the informed consent. Rather than adopting a "directed" approach that recommended HIV testing, the language of the informed consent was "non-directed,'' spelling out all the potential negative consequences of testing and leaving the formulation of a decision entirely up to the individual. This approach to informed consent was based on 20 years of success in the field of 1 In one of the most cogent articles examining the legal capacity of public health authorities to constrain individual behavior through the regulation of public meeting places or contact tracing, Gostin and Curran (1987, p. 217) concluded in 1987 that, "even stricter scrutiny will be applied to public health measures which affect liberty, autonomy, or privacy of human beings. These measures should not be promulgated without searching examinations as to public health need, specificity of the targeted population, and adherence to the principle of the least restrictive alternative."
OCR for page 323
--> genetic counseling and was driven by various consumer movements promoting both patients' rights and autonomy, and a shared medical decision making model that regarded the patient as an active partner along with his or her health care provider. The state health department codified its strategy in two key planning documents: (1) the January 1989 five-year interagency plan, "AIDS: New York's Response," which introduced a number of new initiatives aimed at education (such as HIV/AIDS education incorporated into the core curricula of all public schools and colleges), voluntary counseling and testing, expansion of health services, and preservation of human rights through antidiscrimination legislation and adherence to the principles of informed consent; and (2) the "New York State Principles for the Care of Women and Children with HIV Infection," (New York State AIDS Institute, 1990) drafted after a three day symposium in 1990 at the Mohonk Mountain House in New Paltz, and thereafter known as the "Mohonk Principles.'' The Mohonk symposium, led by the AIDS Institute's Nick Rango, brought together key staff from a number of state agencies, as well as health professionals involved in AIDS-related services and women affected by the epidemic. The document clearly stipulated the state's voluntarist approach. The consensus document urged "routine counseling and voluntary testing of all women of reproductive age," which should be provided in all health care settings; it asserted each woman's right to make her own reproductive choices; and it recommended a program of routine counseling and voluntary testing of postpartum women who may not have received adequate counseling or testing opportunities prior to giving birth. The document further clarified a consensus position opposing mandatory newborn screening, arguing that involuntary testing of the mother (the practical consequence of newborn testing) must be weighed against the state's interest in safeguarding the health and welfare of the infant. It presented the criteria that had to be met before unblinding the newborn screening: "(1) substantial clinical benefit of treatment in HIV-infected newborns has been demonstrated; (2) appropriate clinical services are available to all HIV-infected family members regardless of family resources; (3) a definitive laboratory test becomes available allowing for the detection of HIV infection in newborns (as opposed to the presence of maternal antibodies), or the indicated clinical intervention for infants with HIV infection has been proven to be sufficiently nontoxic to uninfected infants who would receive it because of the presence of maternal HIV antibodies; and (4) a system of voluntary counseling and testing of all women of reproductive age has failed to be effective." The voluntary counseling and testing program at family planning clinics and prenatal care programs was emblematic of this approach. The state intended that every woman of reproductive age seen in a state-regulated facility would be provided with sufficient information to protect herself from being infected and that every woman would also voluntarily take the HIV test in an effort to inform reproductive choices (such as whether to have an abortion or to pursue future
OCR for page 330
--> intensive counseling programs similar to that of Harlem Hospital, which routinely persuaded over 90% of its obstetrical patients to accept HIV testing. Four physicians on the panel—the public health commissioner from Westchester County and three pediatricians—dissented. One of them, Dr. Lou Cooper, the head of the New York chapter of the American Academy of Pediatrics, told the New York Times, "Reliance on counseling that encourages voluntary testing ignores the unacceptably high failure rate of such an approach. In addition, it siphons off resources which could be focused more effectively for needed care." Within days after the Blue Ribbon panel released its report, the Data Safety Monitoring Board of the NIAID interrupted AIDS Clinical Trials Group protocol number 076 (ACTG 076) when it became clear that ZDV administered to pregnant women and newborns could reduce vertical transmission of HIV by 69%. Citing the dramatic, incontrovertible value to intervening prenatally, Cooper reversed his position and sided with the majority view of the panel to focus prevention and case finding efforts on pregnant women rather than newborns. On February 24, 1994, the AIDS Advisory Council adopted the Blue Ribbon panel's recommendation and advised the state to pursue universal voluntary testing. On the same day, a joint Senate-Assembly bill was proposed by Michael Tully, the chair of the Senate Health Committee and Assembly Speaker Sheldon Silver, calling for mandatory counseling and voluntary testing of pregnant women. The sponsors pointed to the recent reports of ZDV's efficacy as a clear mandate to focus efforts on enlisting pregnant women in the detection and care of their HIV-infected babies. The battle over Mayersohn's bill had clearly been joined. Newsday columnist Jim Dwyer, who would later win a Pulitzer Prize for his series of columns on the Baby AIDS legislation, published a column in April, 1994, "A Silence that Kills Children," prompted by a conversation he had with Mayersohn that transpired after he had attended the funeral of a baby who died from AIDS complications (Mayersohn, 1994a). In the column, he quoted pediatrician Stephen Nicholas of Columbia Presbyterian Medical Center as favoring "routine newborn testing, the same we do for syphilis testing." Nicholas, who had been involved in the design and implementation of Harlem Hospital's much-touted High Risk Pregnancy Clinic, told the columnist that he felt that even 90% voluntary agreement to test was not sufficient, "because you're still missing 10%." Throughout the early spring, there was considerable political discussion and negotiation over possible terms of compromise between the Silver-Tully sponsors and the Mayersohn-Velella sponsors. One compromise being considered was directed counseling that urged HIV testing and the written acceptance or refusal of testing at delivery. At the same time, the foster-care agency ABC had renewed its advocacy for allowing HIV testing of foster children without explicit consent of the birth parents, a policy that many saw as linked with the mandatory newborn testing proposals because both would amend the state's confidentiality statute and both would be undertaken on behalf of HIV-infected children. ABC
OCR for page 331
--> and its pro bono counsel had made it clear to the state commissioners of social services and health that they would pursue a lawsuit against Governor Cuomo and the state. On June 6, 1994, only days before the lawsuit was to be filed, the commissioner of social services announced new regulations that would allow foster children to be tested after a good-faith effort to locate the natural parents had been made. The regulations would be adopted on an emergency basis, which meant that within a year the agency would have to hold hearings and adopt the regulations permanently. ABC, satisfied with the compromise, dropped its plans for a lawsuit. Throughout June, the battle over the Baby AIDS bill intensified, particularly since the end of the legislative session was scheduled for the first week of July and there was a major election looming in November. Newsday columnist Dwyer wrote one column referring to the "corrosive influence of a Religious Left" backed by well-paid Albany lobbyists, which was marked by dogma that held that any threat to a woman's right to privacy was a threat to abortion, that any abrogation of the state's confidentiality statute was the first step on a slippery slope to the persecution of people with AIDS, and that mandatory testing would drive mothers away from medical care. New York Times columnist Anna Quindlen (1994) took the opposing view: "The word on the mandatory reporting measure is that it is opposed only by special interest groups, gay organizations obsessed with privacy, and feminists concerned only with women. Why then is it opposed by Lorraine Hale, whose Hale House has been caring for sick and abandoned babies for years?" Quindlen concluded that "the Baby Bill sounds so right; the mothers, with all their many problems, are not so sympathetic. But winning their trust and cooperation, not coercing and blindsiding them, is how real change will occur." The results of ACTG 076 had changed the terms of the debate for a number of individuals and organizations. Both the New York chapter of the American Academy of Pediatrics and the Medical Society of the State of New York reversed their positions on mandatory testing, favoring instead a policy of mandatory counseling for pregnant women and voluntary testing. Given the existence of an effective treatment, a number of clinicians were loathe to institute a policy that might drive any women from care, and a number had seen the clinical opportunity shift from the delivery setting—which many regarded as too late for effective intervention—to the prenatal setting. The Republican candidate for governor, State Senator George Pataki, announced in early June that he favored mandatory HIV testing of newborns, a position that was echoed by the candidate for state attorney general, Dennis Vacco, running on Pataki's ticket. Governor Cuomo had still not taken a public stand. In early spring, months after the AIDS Advisory Council had released its recommendations, Governor Cuomo charged the Task Force on Life and the Law with reviewing the issue of mandatory HIV newborn testing. According to one member of that advisory panel, which often addressed ethical issues of concern to
OCR for page 332
--> the governor, Cuomo wanted to delay his decision until after the gubernatorial reelection campaign. Right up to the end of the legislative session in early July, supporters of the Silver-Tully bill calling for mandatory counseling and voluntary testing believed their bill would pass in the final hours. Even Mayersohn had accepted the likelihood of her opponents' bill passing. "I left at midnight [on the last night of the legislative session] thinking this would pass. [Newsday columnist] Dwyer called me the next morning to say the bill wasn't introduced. It was never put up for a vote. That left an opening for our bill to be reintroduced in the 1995 session." Mayersohn harbored no illusions as to the impact of the upcoming gubernatorial elections. "With Pataki, I had no doubt that if he won we would see a different force at work. The activists would not have the same influence they had under Cuomo." In November 1994, George Pataki narrowly defeated Mario Cuomo for governor. Political Maneuverings, 1995–1996 Shortly after Pataki assumed office, he held to one of his campaign promises to limit government by placing a moratorium on the promulgation of any new regulations. Ironically, this included the Department of Social Services' effort to create permanent rules for the HIV testing of foster children after its emergency rule making of 1994. The Association to Benefit Children felt that its negotiated victory was in jeopardy and began preparing another lawsuit. In mid-March, ABC sued the governor on behalf of "Baby Girl" seeking routine HIV testing for all newborns, and treatment and counseling for all HIV-positive infants, mothers, and other family members. Mayersohn had encouraged the lawsuit, since she felt it would help advance the cause of mandatory testing. The HIV Law Project, a legal advocacy group representing HIV-infected women, petitioned the court to be added as a "defendant-intervenor" since it felt that the state would not adequately represent its own interest in maintaining the voluntary testing program, given the campaign statements of both Pataki and Attorney General Dennis Vacco. There was little doubt as to the new administration's agenda concerning newborn testing. When Pataki's nominee for health commissioner, Dr. Barbara DeBuono, commented in an appointment hearing that she supported voluntary testing over mandatory testing approaches, Mayersohn placed a call to the governor. Within a couple of days, DeBuono had reversed her position and proffered her support for pursuing mandatory newborn testing. Actions at the federal level in the spring of 1995 were felt at the state level as well. In March, Congressmen Ackerman and Coburn introduced H.R.-1289, an amendment to the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act which would require states to disclose the HIV status of newborns.
OCR for page 333
--> The amendment gained broad bipartisan support, including from the congressional Black Caucus and such progressive representatives as Ronald Dellums and Patricia Schroeder. In response, in May 1995 the CDC suspended its anonymous HIV Survey of Childbearing Women. According to one senior New York public health official, the state health department decided to continue its program of newborn surveillance without the $500,000 provided by the CDC. ''After Mayersohn began agitating," the official noted, sharply contrasting the state response to that of the federal public health agency, "it would not have been politically astute to pull it." After Mayersohn and Velella reintroduced their mandatory testing bills, there was again a great deal of movement to strike a compromise before the end of the legislative session in early July. Late in the evening on one of the last nights of the session, a member of Assembly Speaker Silver's staff approached Mayersohn. The speaker was willing to amend the law to allow the health commissioner to order the HIV test, rather than mandate it by law. Mayersohn readily accepted the compromise. This time, as the legislative session drew to a close, Mayersohn was convinced that her position would prevail. As happened the previous year, though, the legislation that everyone expected to pass was not brought to the floor. According to various accounts, the speaker had been approached by Assembly Democrats opposed to mandatory testing, so he had decided instead to await the resolution of the Ackerman-Coburn amendment in the House of Representatives. In September 1995, the state attorney general approached ABC to settle its lawsuit. Since the governor could not change the confidentiality statute by executive order, the state was limited to working within the bounds of an arrangement that included written informed consent. The two sides (absent the HIV Law Project) settled upon a compromise. The state would propose rules by which postpartum women would be approached for consent to have their infant's HIV status disclosed, and there would be a provision allowing a physician to conduct HIV testing if he or she determined that an emergency existed. According to ABC counsel Colin Crawford, in retrospect ABC "could have considered the possibility of voluntary testing following a compelled choice either to learn the results or not, far earlier than we did. We could have come to this realization, moreover, from working even harder than we did to try and accommodate the confidentiality and civil liberties of our opponents." Richard Gottfried, chair of the Assembly Health Committee, was not unhappy with the settlement. "For some people, the ABC lawsuit gave legitimacy to Nettie's position. But, in fact, it was almost exactly what I would have wanted to have as state law." The only critical difference, according to Gottfried, was that the proposed rules would mandate directed HIV counseling only in state-regulated facilities (such as hospitals, clinics, and certain HMO practices), whereas the Silver-Tully bill he had cosponsored would require all physicians—whether regulated or not, public or private—to provide mandatory counseling. In settling the lawsuit, Governor Pataki was quoted in the New York Times as
OCR for page 334
--> saying, "This is as far as we can go in the absence of legislative action." Mayersohn announced she would reintroduce her bill in January 1996. Pataki, supporting Mayersohn, said he would sign the bill if it crossed his desk. Over a period of five months, the state health department worked with the governor's office to develop rules and an implementation plan for what was being called the "Consented Newborn HIV Testing Program." As implemented on May 1, 1996, the regulations required that women in labor must sign a written consent form, and if neither consent nor refusal is present a physician may order the HIV test. If the woman provided written consent, she would receive the results of her newborn's HIV test, would consent to follow-up testing of the baby after discharge to determine if the baby was truly infected, and would authorize the disclosure of the baby's test result to appropriate programs and the state health department to ensure that the baby received follow-up and specialty medical care. The facility providing maternity services would be responsible for identifying a physician to receive the HIV test results, preferably the baby's pediatrician. Post-test counseling would be provided at the time the woman was notified of the test results, and the pediatrician was required to order a polymerase chain reaction (PCR) test on the newborn to determine if the infant was HIV infected or was only manifesting the mother's antibodies. If the state newborn screening program did not receive the PCR specimen within five to six weeks after birth, it would contact the hospital designee or pediatrician for further follow-up. Women could refuse notification of results, in which case the screening would remain anonymous and be used for epidemiologic purposes only. If a woman in the newborn setting did not provide written consent or refusal, her physician could act in the absence of parental consent "when a medical emergency exists for the infant." According to state health department officials, over the nine-month period of the Consented Newborn HIV Testing Program, this emergency provision was exercised only four times—in two cases the babies had been separated from their mothers, and in one case the mother was comatose. Notwithstanding the compromise reached over the lawsuit, in the months surrounding the implementation of the Consented Testing Program the mandatory testing legislation reintroduced by Mayersohn and Velella gained considerable momentum. In late April, House and Senate negotiators came to an agreement over mandatory testing as part of the Ryan White CARE Act reauthorization. House Republicans agreed to support the position of the Senate conference committee, the American Medical Association, and the National Governor's Association calling for a five-year trial period of voluntary testing before instituting mandatory newborn testing. As signed in June, the Ryan White CARE Reauthorization Act required states to demonstrate that they had satisfied one of the following criteria, or face the loss of their Title II funding: either (1) a 50% reduction in AIDS cases from perinatal transmission compared with 1993 data; (2) HIV testing of at least 95% of pregnant women who had received at least two
OCR for page 335
--> prenatal visits prior to 34 weeks gestation; or (3) a program of mandatory testing of all newborns whose mothers had not undergone prenatal HIV testing. Also in June 1996, Assembly Speaker Sheldon Silver reversed his position on mandatory testing legislation and allowed the bill to pass the legislature. According to one legislative insider, "The Assembly leadership did not want to go into 1996 elections with this as an open issue. In 1994, the U.S. House and Senate went Republican, as did the New York governor. In 1996, the Speaker was very concerned this [opposition to mandatory testing] would lead to a loss of a significant number of Assembly seats, and that would then invigorate the Republicans. We could potentially lose majority control. That got played out on a long list of issues, whether criminal justice, or welfare reform, or mandatory testing." On June 26, 1996, Pataki signed the Baby AIDS bill into law. The new law gave the health commissioner the authority to impose newborn HIV tests. According to Speaker Silver, "We're leaving it to the health professionals to make the determination." As expected, Health Commissioner Barbara DeBuono issued a call for developing regulations to put the mandatory newborn HIV screening program into place, and on February 1, 1997, the Comprehensive Newborn Testing Program was implemented. Epilogue In the wake of the mandatory newborn testing policy which began in 1997, Mayersohn returned to her original proposed partner notification legislation from 1993. According to one observer, "The success of the Baby AIDS program [mandatory newborn testing] was a major arguing point in the efforts to pass partner notification, and the lines of support were parallel." A number of county health officials, the state medical society, and a number of physicians supported the effort; similarly, a number of community groups, civil libertarians, and physicians opposed to mandatory newborn testing also opposed the partner notification legislation. The case of Nushawn Williams, an HIV-positive Brooklyn man who infected a number of underage teenage girls through sexual contacts in rural Chautauqua County in 1997, further fueled public debate and interest in the partner notification legislation. According to public reports about the case, although Williams was aware of his HIV-positive status he did not disclose it to the girls with whom he had intercourse. A number have since tested positive for HIV. Mayersohn's reintroduced bill requires providers to solicit the names of sexual contacts and injection drug-using contacts from individuals who test positive for HIV. Physicians, laboratories, coroners, and medical examiners are required to report the names of individuals testing positive and their contacts (if known) to the state health commissioner. In turn, the state will then forward the information to the local health commissioner or district health officer. Local health officers are required to trace the sexual and/or drug-sharing contacts of
OCR for page 336
--> HIV-positive individuals, inform them of their risk, provide counseling, and direct them to testing and treatment centers. Rigorous confidentiality standards are required, and the identity of the index case may not be revealed to the partners who are traced. Furthermore, a special protocol would be developed for individuals at risk of domestic violence. In addition to the "duty to warn," the legislation also allows the commissioner to establish a named HIV registry similar to that in effect in 27 other states. Mayersohn's bill was tabled for further discussion in 1997 and passed both houses of the legislature in the closing days of the 1998 session. The bill was signed into law by Governor Pataki on the last day of the legislative session in June 1998. After regulations are drafted and comments received, the law will go into effect on January 1, 1999. The combined partner notification-named HIV registry legislation signified a further breach of New York's exceptionalist HIV policy. With some notable exceptions—such as the development of Special Needs Plans for HIV-positive Medicaid recipients, rather than pooling them with the rest of the Medicaid managed care population—public health policy regarding HIV-positive individuals has tended toward the more traditional approaches of case finding, containment, and chronic disease management. Under the Pataki administration, the composition of the AIDS Advisory Council has changed as well, since the governor can appoint 9 of the 17 council members. There is less representation from advocacy groups and community interests, and a greater voice of traditionalist public health as represented by several suburban health commissioners. The governor also appointed Mayersohn's legislative counsel, William Viskovitch, to serve on the council. Mayersohn herself has continued to support her agenda on a national scale, through a growing electronic network that includes contacts in Delaware, a medical society in California, congressional staff, an Indiana-based children's publisher, and a number of physicians who treat HIV-positive patients. The state health department's AIDS Institute is no longer entrenched in the HIV policy arena, as it was under Axelrod and, particularly, Rango's direction. As one observer pointed out about the AIDS Institute, "There is no policy agenda now." All policy matters department-wide have been consolidated under a single office reporting directly to the commissioner, such that there is no AIDS policy distinct from that of the entire department. Although the legislative battle over mandatory newborn testing in New York State is over, the legal battle continues. The HIV Law Project, a legal advocacy service for low-income HIV-positive individuals in the Bronx and Manhattan, has pursued a dual strategy: (1) malpractice suits against providers and institutions whose failure to carry out timely and appropriate testing and notification represent an abrogation of the standard of care; and (2) a lawsuit against the state health department for failure to carry out the law fairly, equitably, and with adequate protections. Despite the fact that the former strategy targets individual providers, the objective—as in the latter—is to implicate the law. Since a ruling
OCR for page 337
--> on the HIV Law Project's request for a preliminary injunction against the state has not yet been issued, as of July 1998 New York remained the only state to mandatorily test newborns for HIV and notify the mother of the results. According to data released by the state health department, in the first 11 months of the newborn testing program (February through December 1997), 957 HIV-positive infants were identified out of 236,663 tested. These 957 infants were born to 923 HIV-positive mothers, of whom 96 (10.4%) had not known their HIV status prior to delivery.3 Seventy-seven cases were referred back to the state health department for follow-up when the hospitals or physicians were unable to locate the mothers or persuade them to return for follow-up care. Using AIDS Institute staff in New York City and communicable disease specialists in upstate New York, the state was able to directly locate and notify 68 of the 77 mothers; 5 mothers had moved out of state, and 4 were lost to follow-up. References American Healthline. Stateline—New York: Mothers Will Know Babies' HIV Test Results. October 10, 1995. [www document] URL http://cloakroom.com/pubs/healthline. American Healthline. Politics & policy—Ryan White Act: Includes Mandatory Newborn HIV Testing, May 1, 1996. [www document] URL http://cloakroom.com/pubs/healthline. American Healthline. Politics & Policy—Ryan White Act: House Passes Reauthorization Bill. May 2, 1996. [www document] URL http://cloakroom.com/pubs/healthline. American Healthline. Stateline—New York: Pataki Signs Newborn HIV Testing Law, June 27, 1996. [www document] URL http://cloakroom.com/pubs/healthline. American Healthline. Stateline—New York: Pataki and Legislators Agree on HIV Testing Law. June 6, 1996. [www document] URL http://cloakroom.com/pubs/healthline. Avery GB. Editorial: Out of the vortex—neonatologists' treatment decisions for newborns at risk for HIV. AJPH 85(11):1484–1485, 1995. Baby Girl Doe v. Pataki, Index No. 95-106661 (SupCt NY County, filed July 18, 1997). Bayer R. Perinatal transmission of HIV infection: The ethics of prevention. In: Gostin LO, ed. AIDS and the Health Care System. New Haven: Yale University Press, 1990. Bayer R. AIDS and the future of reproductive freedom. In: Nelkin D, Willis D, Parris S, eds. A Disease of Society. Cambridge, England: Cambridge University Press, 1991. Bayer R. Private Acts, Social Consequences. New Brunswick, NJ: Rutgers University Press, 1991. Bayer R. Public health policy and the AIDS epidemic: An end to exceptionalism? NEJM 324:1500–1504, 1991. Bayer R. Women's rights, babies' interests: Ethics, politics, and science in the debate of newborn HIV screening. In: Minkoff HL, DeHovitz JA, Duerr A, eds. HIV Infection in Women. New York: Raven Press, 1995. Bayer R. Rethinking the testing of babies and pregnant women for HIV infection. Journal of Clinical Ethics 7(1):85–87, 1996. 3 Since the conversion of the infant's HIV status is unknown, one can only estimate the actual numbers of babies who will seroconvert to HIV positivity. Given a range of 10%–25% who might seroconvert, the number of HIV-positive babies ranges from 96 to 239; similarly, the number of HIV-positive infants whose mothers learned their status as a result of the mandatory testing program could range from 10 to 24 in the 11-month reporting period.
OCR for page 338
--> Bayer R, Levine C, Wolf SM. HIV antibody screening: An ethical framework for evaluating proposed programs. JAMA 256(13):1768–1774, 1986. Berger J, Rosner F, Farnsworth P. The ethics of mandatory HIV testing in newborns. Journal of Clinical Ethics 7(1):77–84, 1996. Bernstein N. The secret life of AIDS. Newsday, Jan. 15, 1993. Bernstein N. 'No one would tell me': Wife of AIDS victim was kept in dark. Newsday, Jan. 15, 1993. Bernstein N. Death by silence: A failure to notify costs lives. Newsday , Jan. 15, 1993. Bernstein N. Doctors' orders: No obligation to warn. Newsday, Jan. 17, 1993. Bernstein N. 'Who wants to know they're going to die?' Newsday, Jan. 17, 1993. Bernstein N. In grave danger: NY's partner-notification policy puts women at risk. Newsday, Jan. 17, 1993. Bernstein A. The Newsday interview with Barbara DeBuono. Newsday, p. A23, Mar. 27, 1995. Bunis D, Slackman M. NY plan: AIDS test for all newborns. Newsday p. A4, June 6, 1996. Centers for Disease Control and Prevention. Update: HIV counseling and testing using rapid tests—United States, 1995 . MMWR 47(11):211–215, 1998. Chavkin W, Breitbart V, Wise P. Finding common ground: The necessity of an integrated agenda for women's and children's health. Journal of Law, Medicine & Ethics 22(3):262–269, 1994. Chavkin W, Breitbart V, Wise P. Efforts to reduce perinatal mortality, HIV, and drug addiction: Survey of the states. Journal of the American Medical Womens Association 50(5):164–166, 1995. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331(18):1173–1180, 1994. Crossley M. Of diagnoses and discrimination: Discriminatory nontreatment of infants with HIV infection. Columbia Law Review 93(7):1581–1667, 1993. Curnin K. Newborn HIV screening and NY Assembly bill 6747-B: Privacy and equal protection of pregnant women. Fordham Urban Law Journal 21(3):857–926, 1994. Dwyer J. A silence that kills children. Newsday p. A2, Apr. 15, 1994. Dwyer J. That dirty HIV secret. Newsday, June 1, 1994. Dwyer J. State stands by as babies die. Newsday p. A2, June 8, 1994. Dwyer J. Baby fodder for HIV data. Newsday p. A2, June 27, 1994. Dwyer J. A devastation we didn't stop. Newsday p. A2, May 19, 1995. Dwyer J. No silver lining for AIDS kids. Newsday p. A2, July 5, 1995. Dwyer J. HIV results not positive. Newsday, July 14, 1996. Fleischman A, Dumois A. HIV Testing is not health care. Newsday, Jan. 18, 1994. Fleischman AR, Farber Post L, Neveloff Dubler N. Mandatory newborn screening for HIV. Bull of the NY Academy of Medicine 71(1):5–17, 1994. Goodman E. Need change of attitude on HIV testing. Albany Times Union p. A11, July 18, 1995. Gostin LO, Curran WJ. Legal control measures for AIDS: Reporting requirements, surveillance, quarantine, and regulation of public meeting places. AJPH 77(2):214–218, 1987. Gostin LO, Webber DW. HIV infection and AIDS in the public health and health care systems: The role of law and litigation. JAMA 279(14):1108–1113, 1998. Gottfried RN. The great importance of testing newborns for HIV. Albany Times Union p. A10, Jan. 21, 1994. Gottfried R. Wiser moms, healthier kids. Newsday p. A38, Apr. 26, 1994. Gottfried R. Make counseling mandatory. Newsday p. A40, June 9, 1994. Grondahl P. Screening eases baby disorders. Albany Times-Union p. G1, Dec. 16, 1990.
OCR for page 339
--> Healton C, Messeri P, Abramson D, Howard J, Sorin MD, Bayer R. A balancing act: The tension between case finding and primary prevention strategies in New York State's voluntary HIV counseling and testing program in women's health care settings. American Journal of Preventive Medicine 12 (4 Suppl):53–60, 1996. Hentoff N. Silence - Death. Village Voice, May 11, 1994. Hentoff N. Gary Ackerman's multicultural liberators. Village Voice, May 17, 1995. Hentoff N. The shame of Sheldon Silver. Village Voice, Aug. 1, 1995. Hentoff N. Breakthrough for HIV-positive babies. Washington Post, July 1996. Institute of Medicine. HIV Screening of Pregnant Women and Newborns. Washington, DC: National Academy Press, 1991. Krasinski K, Borkowsky W, Bebenroth T. Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population (letter to the editor). New Engl J Med 318(3):185, 1988. Landesman S, Minkoff H, Holman S, McCalla S, Sijin O. Serosurvey of HIV infection in parturients. JAMA 258(19):2701–2703, 1987. Lester P, Partridge J, Chesney M, Cooke M. The consequences of a positive prenatal HIV antibody test for women. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10(3):341–349, 1995. Levin BW, Krantz DH, Driscoll JM, Fleischman AR. The treatment of non-HIV-related condition in newborns at risk for HIV: A survey of neonatalogists. AJPH 85(11):1507–1513, 1995. Mason-Draffen C. A vote for AIDS tests: Nassau recommends screening pregnant women. Newsday, July 22, 1992. Mayersohn N. It's a baby, not a statistic, stupid. News from Assemblywoman Nettie Mayersohn, 27th Assembly District, 1993. Mayersohn N. The "Baby AIDS" bill. Fordham Urban Law Journal 24(4):721–727, 1997. McFadden RD. David Axelrod, health chief under Cuomo, is dead at 59. NY Times p. D14, July 5, 1994. Minkoff H, Willoughby A. Pediatric HIV disease, zidovudine in pregnancy, and unblinding heelstick surveys. JAMA 274(14):1165–1168, 1995. Nature. Editorial. AIDS and illiberal measures. Nature 325:647, 1987. New York State AIDS Advisory Council. Report of the Subcommittee on Newborn HIV Screening. February 10, 1994. New York State AIDS Institute. Principles for the Care of Women and Children with HIV Infection (the "Mohonk Principles"). 1990. New York State Assembly—Nettie Mayersohn, 1998. [www document] URL http://assembly.state.ny.us/members/bios/mayersn.html. New York State Assembly Bill 6629-A, Senate Bill 4422-A, "HIV Partner Notification Bill," June 18, 1998. New York State Department of Health. HIV counseling and testing of pregnant women and newborns. Memorandum 96-7, Apr. 8, 1996. New York State Department of Health. Maternal–pediatric HIV prevention and care program: HIV counseling and voluntary testing of pregnant women; routine HIV testing of newborns as part of the Comprehensive Newborn Testing Program. Memorandum 97-2, Jan. 24, 1997. New York State Public Health Law. AIDS Institute Advisory Council. Article 27-E, Sec. 2778, amended 1990. Newsday. Editorial. State should tell moms their infants have HIV. Newsday, Aug. 14, 1995. New York Times. Editorial. AIDS babies deserve testing. NY Times p. A16, June 27, 1994. Novick LF, Berns D, Stricof R, Stevens R, Pass K, Wethers J. HIV seroprevalence in newborns in New York State. JAMA 261(12):1745–1750, 1989. Novick LF. HIV seroprevalence surveys: Impetus for preventive activities. AJPH 81 (Suppl):15–21, 1991.
OCR for page 340
--> Novick LF. New York State HIV seroprevalence project: Goals, windows, and policy consideration. AJPH 81(Suppl):11–14, 1991. Novick LF, Glebatis DM, Stricof RL, MacCubbin PA, Lessner L, Berns DS. Newborn seroprevalence study: Methods and results. AJPH 81(Suppl):15–21, 1991. Perez-Rivas M. The Baby AIDS bill: On a crusade—lawmaker's profile grows. Newsday, Mar. 31, 1994. Quindlen A. Take a good, hard look at infant AIDS legislation. Albany Times Union p. A11, June 8, 1994. R.Z. v. Pataki, Index No. 97-112960 (SupCt NY County, filed July 18, 1997). Richardson L. HIV testing project draws complaints. NY Times, June 16, 1997. Riley J. AIDS baby bill favored by GOP guv hopeful. Newsday p. A12, June 11, 1994. Sack K. Battle lines drawn over newborn HIV disclosure. NY Times p. A23, June 26, 1994. Sontag D. HIV testing for newborns debated anew. NY Times p. A1, Feb. 10, 1997. Taylor CL. Baby AIDS test bill fizzling: But deal may be in works. Newsday, May 24, 1994. Teare C, English A. Women, girls, and the HIV epidemic. In: Moss KL, ed. Man-Made Medicine: Women's Health, Public Policy, and Reform. Durham, NC: Duke University Press, 1996. Trug R. Is 'Informed right of refusal' the same as informed consent? Journal of Clinical Ethics 7(1):87–89, 1996. Vacco D. Turning a 'blind' eye to dying babies. Albany Times Union p. A9, Sept. 12, 1995. Wiemer B. Conspiracy of Silence Aids AIDS' spread. Newsday, July 27, 1992.
Representative terms from entire chapter: